Patent · US Active

Thrombin receptor antagonists

US7713999B2 · kind B2 · utility

2Cited by
1References
46Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 10, 2007
Grant dateMay 11, 2010
Priority date—
Expiry dateMay 26, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Heterocyclic-substituted tricyclics of the formulaor a pharmaceutically acceptable salt thereof, wherein:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.